| 标题 |
MOR202, a novel anti-CD38 monoclonal antibody, in patients with relapsed or refractory multiple myeloma: a first-in-human, multicentre, phase 1–2a trial |
| 网址 | |
| DOI | |
| 其它 |
期刊:The Lancet Haematology 作者:Marc S. Raab; Monika Engelhardt; Antje Blank; Hartmut Goldschmidt; Hermine Agis; et al 出版日期:2020-03-11 |
| 求助人 | |
| 下载 | 求助已完成,仅限求助人下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)